4.8 Article

Intravenous administration of BCG in mice promotes natural killer and T cell-mediated antitumor immunity in the lung

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cell Biology

Tumor-associated fibrosis impairs immune surveillance and response to immune checkpoint blockade in non- small cell lung cancer

Brett H. Herzog et al.

Summary: Non-small cell lung cancer (NSCLC) is a major cause of cancer-related deaths. Fibrosis in NSCLC leads to reduced immune surveillance and poor responsiveness to immune checkpoint blockade. Fibrosis-induced alterations in dendritic cells and macrophage phenotypes contribute to immunosuppression. Targeting fibrosis through transforming growth factor-II receptor signaling overcomes immunotherapeutic resistance and enhances the efficacy of immune checkpoint blockade in the context of chemotherapy.

SCIENCE TRANSLATIONAL MEDICINE (2023)

Article Medicine, Research & Experimental

Dual IL-6 and CTLA-4 blockade regresses pancreatic tumors in a T cell- and CXCR3-dependent manner

Michael Brandon Ware et al.

Summary: This study demonstrates that anti-IL-6 and anti-CTLA-4 antibodies can enhance antitumor immune responses to pancreatic cancer. Dual blockade of IL-6 and CTLA-4 inhibits tumor growth by inducing T cell infiltrations and secretion of IFN-gamma by CD4+ T cells. The efficacy of this combination therapy is dependent on the CXCR3 axis and the presence of both CD4+ and CD8+ T cells.

JCI INSIGHT (2023)

Review Immunology

Roles of natural killer cells in immunity to cancer, and applications to immunotherapy

Natalie K. Wolf et al.

Summary: This review explains the role of natural killer (NK) cells in promoting immunity to tumors and discusses various therapeutic approaches being developed for cancer patients. Recent advances have improved our understanding of NK cells in tumor and viral immunity, showcasing their potential for immunotherapy for cancer.

NATURE REVIEWS IMMUNOLOGY (2023)

Article Oncology

Safety and preliminary immunogenicity of JNJ-64041809, a live-attenuated, double-deleted Listeria monocytogenes-based immunotherapy, in metastatic castration-resistant prostate cancer

Charles G. Drake et al.

Summary: JNJ-809 demonstrated manageable safety and transiently induced peripheral cytokines. Limited antigen-specific immune responses were observed, but did not translate into objective clinical responses.

PROSTATE CANCER AND PROSTATIC DISEASES (2022)

Article Cell Biology

NK cells with tissue-resident traits shape response to immunotherapy by inducing adaptive antitumor immunity

Nicole Kirchhammer et al.

Summary: This study demonstrates that therapeutic targeting of the IFN-gamma-IL-12 pathway relies on tissue-resident NK cells to orchestrate an anti-tumor microenvironment. By inducing the expression of CCL5, IFN-gamma-inducing therapies and PD-1 blockade can increase the infiltration of NK cells and enhance immune cell interactions, leading to improved anti-tumor immunity and overcoming treatment resistance.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Article Multidisciplinary Sciences

Therapeutic KRASG12C inhibition drives effective interferon-mediated antitumor immunity in immunogenic lung cancers

Edurne Mugarza et al.

Summary: Recently developed KRAS(G12C) inhibitory drugs benefit lung cancer patients with KRAS(G12C) mutations, but drug resistance is common. These drugs indirectly affect antitumor immunity by reversing immunosuppression caused by oncogenic KRAS. However, the combination of KRAS(G12C) inhibitors with immune checkpoint blockade only provides synergistic benefit in highly immunogenic tumor models.

SCIENCE ADVANCES (2022)

Review Oncology

Pulmonary metastatic melanoma: current state of diagnostic imaging and treatments

Kermit S. Zhang et al.

Summary: Melanoma is the deadliest form of skin cancer, primarily occurring in the skin but can also be found in other organs. Pulmonary melanoma is rare, and there is limited understanding of its pathophysiology and management.

MELANOMA MANAGEMENT (2021)

Article Immunology

Intravenous administration of BCG protects mice against lethal SARS-CoV-2 challenge

Kerry L. Hilligan et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Review Medicine, General & Internal

Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review

Leah H. Biller et al.

Summary: Colorectal cancer is the third most common cause of cancer mortality worldwide. For patients diagnosed with metastatic colorectal cancer, approximately 70% to 75% can survive beyond 1 year. Tailoring treatments based on the molecular and pathologic features of the tumor has shown to improve overall survival rates.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Immunology

Natural Killer Anti-Tumor Activity Can Be Achieved by In Vitro Incubation With Heat-Killed BCG

Gloria Esteso et al.

Summary: The use of Natural Killer cell receptors in immunotherapy is a promising area of research, with cytokine activation inducing potent NK anti-tumor responses. BCG therapy has been shown to activate cytotoxic NK cells that efficiently recognize bladder cancer cells, demonstrating different components of mycobacteria can stimulate various immune subpopulations suitable for cancer elimination.

FRONTIERS IN IMMUNOLOGY (2021)

Review Immunology

Harnessing the cDC1-NK Cross-Talk in the Tumor Microenvironment to Battle Cancer

Johanna Bodder et al.

Summary: Immunotherapeutic approaches have revolutionized the treatment of diseases like cancer, with a focus on modulating anti-tumor immune responses. Natural killer (NK) cells and dendritic cells (DCs) play crucial roles in cancer immunotherapy, and their bidirectional cross-talk within the tumor microenvironment is essential for treatment success.

FRONTIERS IN IMMUNOLOGY (2021)

Review Oncology

First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma: What Are the Most Appropriate Combination Therapies?

Yann-Alexandre Vano et al.

Summary: The first-line treatment options for metastatic clear cell renal cell carcinoma have significantly increased, with a recommended therapeutic strategy based on a combination, but the choice between dual immunotherapy or immunotherapy combined with an antiangiogenic drug is not clearly standardized. Multiple phase III trials have shown the superiority of combination therapy over monotherapy, but unresolved issues include the relevance of treatment options based on the patient's profile and consideration of subsequent treatments.

CANCERS (2021)

Article Immunology

Pulmonary BCG induces lung-resident macrophage activation and confers long-term protection against tuberculosis

Elena Mata et al.

Summary: In this study, pulmonary delivery of BCG was shown to preactivate alveolar macrophages, leading to efficient containment of Mtb and potential protection against respiratory pathogens. The results suggest the generation of a trained innate memory-like response in alveolar macrophages induced by pulmonary BCG vaccination, even after vaccine clearance. Additionally, BCG-induced innate activation also provided heterologous protection against Streptococcus pneumoniae challenge.

SCIENCE IMMUNOLOGY (2021)

Article Immunology

Lack of CD8+ T cell effector differentiation during priming mediates checkpoint blockade resistance in non-small cell lung cancer

Brendan L. Horton et al.

Summary: The study suggests that in non-small cell lung cancer, the response of CD8(+) T cells to immune checkpoint blockade is influenced by programmed cell death ligand 1 expression induced by interferon-gamma-producing tumor-infiltrating T cells. Tumors with CD8(+) T cell infiltrate may not respond to immune checkpoint blockade due to the presence of a specific CD8(+) T cell dysfunction program in the tumor microenvironment.

SCIENCE IMMUNOLOGY (2021)

Review Oncology

Therapeutic Targeting of the Tumor Microenvironment

Leire Bejarano et al.

Summary: This review provides a comprehensive analysis of the current therapies targeting the TME, combining a discussion of the underlying basic biology with clinical evaluation of different therapeutic approaches, and highlighting the challenges and future perspectives.

CANCER DISCOVERY (2021)

Article Multidisciplinary Sciences

Prevention of tuberculosis in macaques after intravenous BCG immunization

Patricia A. Darrah et al.

NATURE (2020)

Article Multidisciplinary Sciences

A conserved dendritic-cell regulatory program limits antitumour immunity

Barbara Maier et al.

NATURE (2020)

Article Immunology

NK cells mediate clearance of CD8(+) T cell-resistant tumors in response to STING agonists

Christopher J. Nicolai et al.

SCIENCE IMMUNOLOGY (2020)

Article Oncology

Visualizing Synaptic Transfer of Tumor Antigens among Dendritic Cells

Megan K. Ruhland et al.

CANCER CELL (2020)

Article Immunology

Type 1 conventional dendritic cells are systemically dysregulated early in pancreatic carcinogenesis

Jeffrey H. Lin et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2020)

Article Medicine, General & Internal

Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC

Roy S. Herbst et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Immunology

Dendritic cells in cancer immunology and immunotherapy

Stefanie K. Wculek et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Article Multidisciplinary Sciences

Crizotinib-induced immunogenic cell death in non-small cell lung cancer

Peng Liu et al.

NATURE COMMUNICATIONS (2019)

Article Multidisciplinary Sciences

Enhanced adaptive immune responses in lung adenocarcinoma through natural killer cell stimulation

Leah Schmidt et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Article Cell Biology

Natural Killer Cells Suppress T Cell-Associated Tumor Immune Evasion

Andrew J. Freeman et al.

CELL REPORTS (2019)

Review Oncology

The lung microenvironment: an important regulator of tumour growth and metastasis

Nasser K. Altorki et al.

NATURE REVIEWS CANCER (2019)

Article Medicine, Research & Experimental

PD-L1 on host cells is essential for PD-L1 blockade-mediated tumor regression

Haidong Tang et al.

JOURNAL OF CLINICAL INVESTIGATION (2018)

Article Medicine, Research & Experimental

Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression

Heng Lin et al.

JOURNAL OF CLINICAL INVESTIGATION (2018)

Review Biochemistry & Molecular Biology

Understanding the tumor immune microenvironment (TIME) for effective therapy

Mikhail Binnewies et al.

NATURE MEDICINE (2018)

Article Biochemistry & Molecular Biology

A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments

Kevin C. Barry et al.

NATURE MEDICINE (2018)

Article Oncology

STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma

Ferdinandos Skoulidis et al.

CANCER DISCOVERY (2018)

Article Multidisciplinary Sciences

Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti-PD-L1)

Marcin Kowanetz et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Article Multidisciplinary Sciences

High systemic IL-6 is associated with worse prognosis in patients with non-small cell lung cancer

Estela Maria Silva et al.

PLOS ONE (2017)

Review Multidisciplinary Sciences

T cell exclusion, immune privilege, and the tumor microenvironment

Johanna A. Joyce et al.

SCIENCE (2015)

Article Immunology

BCG-induced trained immunity in NK cells: Role for non-specific protection to infection

Johanneke Kleinnijenhuis et al.

CLINICAL IMMUNOLOGY (2014)

Article Medicine, General & Internal

Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer

Julie R. Brahmer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Cell Biology

Preexisting BCG-Specific T Cells Improve Intravesical Immunotherapy for Bladder Cancer

Claire Biot et al.

SCIENCE TRANSLATIONAL MEDICINE (2012)

Review Oncology

The blockade of immune checkpoints in cancer immunotherapy

Drew M. Pardoll

NATURE REVIEWS CANCER (2012)

Review Immunology

PD-1 and its ligands in tolerance and immunity

Mary E. Keir et al.

ANNUAL REVIEW OF IMMUNOLOGY (2008)

Article Multidisciplinary Sciences

Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis

Hans-Willi Mittruecker et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)